NCT04711200View on ClinicalTrials.gov

LYell SYndrome MEsenchymal Stromal Cells Treatment

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

April 15, 2024

Primary Completion Date

April 30, 2027

Study Completion Date

April 30, 2027

Conditions
Epidermal NecrolysisLyell SyndromeToxic Epidermal NecrolysisOverlap SyndromeMesenchymal Stromal CellsAdipose Derived Stromal Cells
Interventions
DRUG

Adipose derived stromal cells intravenously injected

2×10\^6/kg of Adipose derived stromal cells A single injection at D0 (performed maximum three days post-admission).

Trial Locations (1)

Unknown

RECRUITING

Henri Mondor, Créteil

All Listed Sponsors
lead

Assistance Publique - Hôpitaux de Paris

OTHER